AMX three-lens brief
Evidence-based stock research on AMX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 12.1pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 12.1pp over 30 days.
- Analyst mean target $29.44 — 29% above current (15 analysts).
AMX closed at $22.82 (-1.21%) as of 2026-09-11. Market cap: $68.27B. P/E (trailing) 13.2. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $29.44 — 29% above current (15 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 12.1pp over 30 days.. Last quarter: Revenue $241.07B, net income $24.33B, free cash flow $153.24B.
Why three lenses on AMX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMX brief"></iframe>